Source: Virtual Congress 2021 – Clinical trials in airway diseases: novel treatments and new evidence



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kirk (Clydebank, United Kingdom), D. Slebos (Groningen, Netherlands), M. Kornaszweska (Cardiff, United Kingdom), P. Shah (London, United Kingdom), K. Carron (Menen, Belgium), H. Mal (Paris, France), C. Pison (Grenoble, France), N. Downer (Sutton-in-Ashfield, United Kingdom), K. Darwiche (Essen, Germany), J. Rao (Sheffield, United Kingdom), R. Hübner (Berlin, Germany), V. Trosini-Desert (Paris, France), R. Eberhardt (Heidelberg, Germany), F. Herth (Heidelberg, Germany), E. Derom (Ghent, Belgium), C. Marquette (Nice, France), N. SHARGILL (Redwood City, CA, United States of America), S. Kemp (London, United Kingdom). Durability of Zephyr Valve treatment: 24-month follow-up in the TRANSFORM Study. 1201

Member's Comments

No comment yet.

Related content which might interest you: The REACH study, a randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System endobronchial therapy for severe emphysema: 12 month follow-up results. Source: International Congress 2017 – Interventional pulmonology highlights 2017 Year: 2017 Dupilumab Efficacy in Asthma Patients With FEV1 60–80% Predicted on Medium-Dose ICS: LIBERTY ASTHMA QUEST Study Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Outcome of smoking-cessation and reduction in hospital-staff, a one-year follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 447s Year: 2001 Late Breaking Abstract - Prolonged azithromycin maintenance treatment in patients with COPD, a follow-up of the COLUMBUS trial Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Late Breaking Abstract - Endobronchial Valves for Severe Emphysema – 12-month Results of the EMPROVE Trial Source: International Congress 2018 – Interventional pulmonology highlights in 2018: ELVR, TLD and BT Year: 2018 The ARROW Study: A Phase 2, Prospective, Randomized, Double-Blind, Placebo-Controlled Study of Selonsertib in Subjects with Pulmonary Arterial Hypertension Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials Year: 2017 Late Breaking Abstract - Bronchoscopic Thermal Vapor Ablation (BTVA) Outcomes at 12 months in Emphysema Patients with Severe Hyperinflation, a STEP-UP RCT Subgroup Analysis Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Real-World Experience with dupilumab in Severe Asthma: One year data from an Italian Named Patient Program Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Treatment With Baricitinib for Patients With COVID-19 Infections: A Case-Series Study Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Adherence to Home Mechanical Ventilation over 10-Years:A Retrospective, Single-Centre Cohort Study Source: Virtual Congress 2020 – Non-invasive ventilation during acute and chronic respiratory failure: technical aspects, adherence and effects Year: 2020 Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT) Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 EuSOS study (European Surgical Outcome Study) Source: Annual Congress 2013 –Post-operative pulmonary complications: myth or reality ? Year: 2013 Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019 Multicenter, Prospective Trial: Comparing Yield and Performance of Virtual Bronchoscopic Navigation With and Without Radial-EBUS Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound Year: 2020 Late Breaking Abstract - Short 12-month regimen with intravenous linezolid for pre-XDR TB: treatment outcomes and 24 months follow-up results Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019 Improvements in Clinical Outcomes Associated with Reduction in Hyperinflation with Zephyr Valves Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Late Breaking Abstract - Sensibility and specificity of the “SLEEP CLINICAL RECORD” Protocol  in Brazilian children. Source: International Congress 2018 – New ideas about respiratory and sleep physiology in children Year: 2018 Late Breaking Abstract - 1-year follow-up of pulmonary tele-rehabilitation versus conventional pulmonary rehabilitation: A multicenter, single blinded, superiority RCT Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019 Home Noninvasive Ventilation with Built-in Software in Chronic Hypercapnic COPD Patients: a Mid-term Prospective, Multicenter, Randomized, Controlled Trial Source: International Congress 2018 – New insights in the management of chronic respiratory failure Year: 2018 Clinical Characteristics and Treatment Outcome of Multidrug-Resistant Tuberculosis (MDR-TB) in a Tertiary Centre in Malaysia: A Two-year Experience Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019